Alphatec Spine's Financials - Craft

$24.4 M

Revenue Q2, 2017

$54.1 M

Mkt cap, 25-Apr-2018

Gross profit (Q2, 2017)15.7 M

Gross profit margin (Q2, 2017), %64.6%

Net income (Q2, 2017)(2.7 M)

EBIT (Q2, 2017)(735 K)

Cash, 30-Jun-201719.1 M

EV37.3 M

Revenue/Financials

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Revenue	204.7 m	207 m	185.3 m	120.2 m
Revenue growth, %		1%	(10%)	(35%)
Cost of goods sold	78.7 m	61.8 m	63.7 m	44.1 m
Gross profit	126.1 m	145.1 m	121.5 m	76.1 m
Gross profit Margin, %	62%	70%	66%	63%
Sales and marketing expense				51 m
R&D expense				9.2 m
General and administrative expense				26.3 m
Operating expense total				86.5 m
EBIT	(73.4 m)	1.8 m	(172.4 m)	(15.4 m)
EBIT margin, %	(36%)	1%	(93%)	(13%)
Interest expense	4 m	13.6 m	12.6 m	5.4 m
Interest income	6 k	10 k	53 k	3 k
Pre tax profit			(178 m)
Income tax expense	3.2 m	1.1 m	681 k	(4.6 m)
Net Income	(82.2 m)	(12.9 m)	(178.7 m)	(29.9 m)

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Revenue	50.2 m	49.2 m	53.2 m	51 m	48.6 m	46.6 m	43 m	44.8 m	43.8 m	26.7 m	28 m	24.4 m
Cost of goods sold	25.5 m	15.4 m	16.6 m	14.3 m	15.3 m	18.7 m	14.2 m	13.5 m	15.5 m	10.8 m	11.2 m	8.6 m
Gross profit	24.7 m	33.7 m	36.6 m	36.7 m	33.3 m	27.9 m	28.8 m	31.2 m	28.3 m	15.9 m	16.8 m	15.7 m
Gross profit Margin, %	49%	69%	69%	72%	68%	60%	67%	70%	65%	59%	60%	65%
Sales and marketing expense	18.1 m	18.1 m	19.8 m	18.6 m	18.2 m	16.6 m	17.1 m	19.1 m	18.1 m	11.8 m	11.1 m	10.3 m
R&D expense	3 m	4.2 m	4.5 m	4.4 m	3.9 m	3.9 m	1.9 m	3.7 m	2.1 m	1.1 m	1.4 m	990 k
General and administrative expense	11.4 m	14.2 m	9.2 m	10.2 m	9.1 m	9.2 m	8.1 m	10.6 m	8.3 m	4.1 m	6.2 m	5.4 m
Operating expense total	37.4 m	38 m	34.3 m	34.6 m	31.8 m	30.4 m	193.4 m	34.6 m	29.1 m	20.4 m	20.2 m	16.5 m
EBIT	(13.2 m)	(4.7 m)	1.8 m	1.7 m	1.1 m	(2.8 m)	(164.9 m)	(3.7 m)	(1.2 m)	(4.5 m)	(3.4 m)	(735 k)
EBIT margin, %	(26%)	(10%)	3%	3%	2%	(6%)	(384%)	(8%)	(3%)	(17%)	(12%)	(3%)
Interest expense	1 m	1.7 m	3.7 m	3.9 m	3.4 m	3 m	3.1 m	3.4 m	3.7 m	1.1 m	2 m	1.9 m
Interest income	2 k	3 k	3 k	2 k	7 k	12 k	18 k	20 k	16 k
Income tax expense	500 k	669 k	307 k	(28 k)	902 k	253 k	(1.7 m)	586 k	600 k	(5 m)	49 k	15 k
Net Income	(14.5 m)	(6.7 m)	(2.9 m)	(3 m)	(4.6 m)	(3.9 m)	(160.3 m)	(6.6 m)	(5.2 m)	(13.7 m)	(5.5 m)	(2.7 m)

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Cash	21.3 m	19.7 m	11.2 m	19.6 m
Accounts Receivable	41.4 m	40.4 m	38.3 m	18.5 m
Inventories	7.7 m	5.5 m	5.1 m	30.1 m
Current Assets	113.7 m	113.1 m	101.9 m	72.8 m
PP&E	28 m	26 m	21.9 m	15.1 m
Goodwill	183 m	171.3 m
Total Assets	365.6 m	344.9 m	146.7 m	94.2 m
Accounts Payable	10.8 m	10.1 m	14.2 m	8.7 m
Short-term debt	4.9 m	8.1 m	80.1 m	3.1 m
Current Liabilities	79.7 m	63.6 m	125.4 m	40.1 m
Long-term debt
Total Debt				3.1 m
Additional Paid-in Capital	403.6 m	413.9 m	416.9 m	419.8 m
Retained Earnings	(235.7 m)	(248.6 m)	(427.2 m)	(457.2 m)
Debt to Assets Ratio				0 x

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Cash	18.7 m	23.8 m	19 m	20.2 m	11.4 m	8.9 m	10.5 m	7.8 m	9.3 m	25.6 m	25.5 m	19.1 m
Accounts Receivable	41.7 m	38.8 m	44.7 m	40.1 m	38.9 m	38.9 m	36.3 m	39.4 m	36.5 m	16.5 m	14.2 m	13.1 m
Inventories	43.1 m	42.5 m	42.4 m	42 m	41.8 m	41.2 m	42.3 m	48 m	44.1 m	27.7 m	30.1 m	29.8 m
Current Assets	112.5 m	135.5 m	117.4 m	112.7 m	102.5 m	100.1 m	100.3 m	100.3 m	93.7 m	75.6 m	72.4 m	64.2 m
PP&E	29.5 m	28.1 m	27.4 m	26.5 m	25.9 m	23.8 m	23.7 m	22.7 m	21.6 m	13.7 m	15.4 m	14.5 m
Goodwill	181.4 m	183.1 m	182.3 m	175.1 m	161.7 m	163.8 m
Total Assets	366.1 m	386.3 m	364.7 m	348.6 m	320.1 m	314.2 m	148.4 m	145.4 m	136.5 m	96 m	93.6 m	84.2 m
Accounts Payable	14.2 m	16.5 m	14 m	11.3 m	8.9 m	10.4 m	10.8 m	19.3 m	17.4 m	6.8 m	4.2 m	2.9 m
Short-term debt	5 m	4.2 m	5.9 m	8 m	7.3 m	6.8 m	59 m	78.1 m	75.4 m	2.6 m	2.6 m	2.3 m
Current Liabilities	56.4 m	94.4 m	69.8 m	66.2 m	56.7 m	53.3 m	98.6 m	129.6 m	125.2 m	42.4 m	33.3 m	29.6 m
Total Debt	5 m	4.2 m	5.9 m	8 m	7.3 m	6.8 m	59 m	78.1 m	75.4 m	2.6 m	2.6 m	2.3 m
Additional Paid-in Capital	402.3 m	404.5 m	411 m	412.6 m	415.2 m	416.7 m	416.6 m	417 m	417.4 m	418.9 m	437.5 m	438 m
Retained Earnings	(175.3 m)	(242.4 m)	(245.3 m)	(248.3 m)	(253.1 m)	(257.1 m)	(417.3 m)	(433.9 m)	(439.1 m)	(452.8 m)	(462.7 m)	(465.4 m)
Total Equity	229 m					133.6 m
Financial Leverage	1.6 x					2.4 x

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Net Income	(82.2 m)	(12.9 m)	(178.7 m)	(29.9 m)
Depreciation and Amortization	26.3 m	18.4 m	19 m	934 k
Accounts Receivable	(1.9 m)	(1 m)	1.2 m	8 m
Inventories	(4.4 m)	(4.3 m)	(5.5 m)	(5.7 m)
Accounts Payable	(3.9 m)	(1 m)	3.2 m	(4.9 m)
Cash From Operating Activities	7.8 m	(20.3 m)	10.1 m	(10 m)
Purchases of PP&E	(14.4 m)	(11.3 m)	(12.2 m)	(8.9 m)
Cash From Investing Activities	(19.1 m)	(11 m)	(12.2 m)	62 m
Short-term Borrowings	(2.7 m)	(5.8 m)	(8.2 m)	(54.4 m)
Cash From Financing Activities	10.7 m	30.7 m	(6.5 m)	(43.4 m)
Interest Paid	4 m	5.9 m	7.6 m	7.4 m
Income Taxes Paid	1.8 m	565 k	621 k	920 k

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017
Net Income	(14.5 m)	(6.7 m)	(2.9 m)	(3 m)	(4.6 m)	(3.9 m)	(160.3 m)	(6.6 m)	(5.2 m)	(13.7 m)	(5.5 m)
Depreciation and Amortization											172 k
Accounts Receivable			44.7 m	40.1 m	38.9 m	38.9 m	36.3 m	39.4 m	36.5 m	16.5 m	14.2 m
Accounts Payable			14 m	11.3 m	8.9 m	10.4 m	10.8 m	19.3 m	17.4 m	6.8 m	4.2 m

Report incorrect company information

View Alphatec Spine profile

Competitors

Bigfoot Biomedical

Health - Private

Health - Private

Health - Public

Health - Public

Compare competitors